文献速递功能神经外科神经重症

延迟释放抗生素对植入式神经调控装置术后伤口感染率的影响

The effect of delayed-release antibiotics on the rate of postoperative wound infection for implanted neuromodulatory devices.
PubMed 文献 · J Neurosurg · 2025-01-31

单术者比较万古霉素浸渍可吸收硫酸钙延迟释放珠在植入式神经调控装置植入/更换中与既往对照的感染率。2019-2022年珠组665次手术(611例)感染率1.5%,2016-2019年对照组393次手术(379例)感染率3.6%(p=0.03);仅脑深部电刺激发生器亚组差异显著(对照组3.4% vs 珠组0.2%,p=0.002,h=0.27)。

要点

  • 万古霉素浸渍珠组术后伤口感染率1.5%(10例)低于对照组3.6%(14例),p=0.03。
  • 仅脑深部电刺激发生器亚组感染率显著降低:对照组3.4% vs 珠组0.2%,p=0.002,效应量h=0.27。
  • 研究者认为万古霉素浸渍可吸收硫酸钙珠与植入装置术后感染率降低相关。

核心结论

  • 使用万古霉素浸渍可吸收硫酸钙珠与植入式装置术后感染率降低相关,尤其在脑深部电刺激初次植入和更换手术中。

研究设计与样本

  • 单术者研究,比较2019-2022年使用万古霉素浸渍可吸收硫酸钙珠的植入式神经调控装置(泵、发生器、刺激器)初次植入或更换手术患者与2016-2019年未使用抗生素珠的对照患者。
  • 珠组共665次手术(611例患者),对照组共393次手术(379例患者)。
  • 术后感染状态及去标识人口学和临床数据取自电子健康记录,按抗生素珠使用、装置类型及1年内需取出的感染分层。
  • 统计采用独立t检验、Fisher精确检验和卡方检验,α设为0.05,效应量用Cohen h统计量计算。

主要发现

  • 术后伤口感染率珠组为1.5%(10例患者),对照组为3.6%(14例患者),p=0.03。
  • 按装置类型分层,仅脑深部电刺激发生器亚组感染率显著降低:对照组3.4% vs 珠组0.2%,p=0.002,对应小到中等效应量(h=0.27)。

临床怎么用

  • 作者认为使用万古霉素浸渍可吸收硫酸钙珠与植入式装置术后感染率降低相关,尤其适用于脑深部电刺激初次植入和更换手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Implanted neuromodulatory devices are important for the surgical management of pain, epilepsy, movement disorders, and spasticity. These devices are surgically implanted, but many must be periodically explanted and replaced as batteries deplete or devices fail. Replacement surgery risks further infections that require device explantation, incur large financial costs, and reduce patient quality of life. To reduce infection rates, a single surgeon began using vancomycin-impregnated absorbable calcium sulfate delayed-response beads with neuromodulatory device and intrathecal pump primary implantations and replacements. The infection rates when using vancomycin-impregnated beads were compared with previously published rates from the same surgeon. METHODS: Patients were identified who underwent primary placement or replacement of an implanted neuromodulatory control device (pumps, generators, and stimulators) with vancomycin-impregnated absorbable calcium sulfate beads between 2019 and 2022. Control data were obtained from patients who underwent surgery prior to the start of using antibiotic beads (2016-2019). Postoperative infection status as well as de-identified demographic and clinical data were extracted from electronic health records. Patients were stratified by use of antibiotic beads, device type, and whether they had an infection within 1 year requiring explantation. Statistical comparisons were made using independent t-tests, Fisher's exact test, and the chi-square test, with α set at 0.05. Effect size was calculated using Cohen's h statistic. RESULTS: A total of 665 surgeries were included for 611 patients who received antibiotic beads with device implantation, compared to 393 surgeries for 379 patients without antibiotic beads. The postoperative wound infection rate was 1.5% (n = 10 patients) versus 3.6% (n = 14 patients) for antibiotic beads versus controls (p = 0.03). When stratified by device type, a significant reduction in infection rate was found only with deep brain stimulation (DBS) generators (3.4% for controls vs 0.2% for beads, p = 0.002), which corresponds to a small to medium effect size (h = 0.27). CONCLUSIONS: The use of vancomycin-impregnated absorbable calcium sulfate beads was associated with a reduced rate of postoperative infection rates with implantable devices, and specifically for DBS primary implantation and replacement surgeries.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Cleary DR, Palan MJ, Useinovic N, et al. The effect of delayed-release antibiotics on the rate of postoperative wound infection for implanted neuromodulatory devices. J Neurosurg. 2025. PMID: 39889284. doi:10.3171/2024.9.JNS241705

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。